Trial
NCT00894075
Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
—
Condition
Hypophosphatasia
Intervention
ENB-0040
Why stopped
Withdrawn pending further review of clinical design.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-04